Mersana Therapeutics is now a part of Day One Biopharmaceuticals

For more information, visit: https://www.dayonebio.com/

Other, Other, Publications

Comparison of NaPi2b Expression From Paired Tissue Samples in a Clinical Study of Upifitamab Rilsodotin (UpRi; XMT-1536) Supports a Strategy of Testing in Archival Material

Read More